BUY Dr. Lal Path Labs Ltd. — Prakash Gaba
byPrakash GabaHorizon: NA (inferred Swing (≤2wk))24 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
4 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·24 Sept · today
Indian Diagnostic Giants Post Strong Q1 FY27 Growth Amid Stable Pricing
NewsGoogle News·13 Sept · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Dr. Lal Path Labs
- BUY — Amit Seth9 Nov 2026 · Same day · target ₹2,120 · Expired
- BUY — Sudeep Shah, SBICAP Securities9 Nov 2026 · ~2 weeks · target ₹2,150 · Active
- BUY — Shrikant Chouhan, Kotak Securities5 Nov 2026 · ~2 weeks · target ₹2,150 · SL hit
- SELL — Citigroup5 Nov 2026 · ~1 year · target ₹1,750 · Active
- BUY — Citigroup5 Nov 2026 · ~1 year · target ₹2,380 · Active
More from Prakash Gaba
- BUY Bharti Airtel13 Nov 2026 · Next day · target ₹2,150 · Active
- BUY Jindal Saw13 Nov 2026 · ~2 weeks · target ₹270 · Active
- BUY KRBL13 Nov 2026 · ~2 weeks · target ₹460 · Active
- SELL Ashok Leyland13 Nov 2026 · ~2 weeks · target ₹165 · Active
- SELL HDFC Bank13 Nov 2026 · Same day · target ₹780 · SL hit

